Diffuse (interstitial) lung disease includes a wide variety of relatively uncommon conditions presenting with characteristic clusters of clinical features and marked by an immune response.

Antigen processing and presentation are components of the immune response, and it is thought that the likely candidate genes predisposing patients to diffuse lung diseases are those of the major ...

Lung cancer arises in tissues of the lung, usually in the cells lining air passages. The two main types are small-cell lung cancer and non-small-cell lung cancer, according to the shape of cells ...

Despite advances in therapeutic approaches, lung cancer remains the leading cause of cancer-related deaths. To understand the molecular programs underlying lung cancer initiation and maintenance, we ...

Lung nodules are small growths in your lungs, less than 30 millimeters in diameter. Many nodules aren’t cancerous, but the risk becomes higher with increased size. A lung nodule is an irregular ...

Sep. 12, 2024 — Researchers examined the impact of obesity in relation to treatment and mortality from data on over 500,000 lung cancer patients. This study suggests that immunotherapy may not ...

June 13, 2024 — The reason why targeted treatment for non-small cell lung cancer fails to work for some patients, particularly those who have never smoked, has been ... Lung Cancer Study Offers ...

It works by presenting the immune system with tumour markers from non-small cell lung cancer, the most common form of the disease, to prime the body to fight cancer cells expressing these markers.

If you have a nagging cough, feel bubbling or wheezing in your chest, and can’t catch your breath, you may have some form of a lung infection, also known as pneumonia. This WebMD slideshow tells ...

The Lung Institute provides comprehensive diagnostics and treatments to patients with illnesses that affect the lungs and breathing, including lung cancer, chronic obstructive pulmonary disease, ...

In a significant breakthrough, the world’s first mRNA lung cancer vaccine trials have been launched across seven countries, ...